Literature DB >> 16958133

Body weight in patients with Parkinson's disease.

Cornelius G Bachmann1, Claudia Trenkwalder.   

Abstract

There is some evidence suggesting that Parkinson's disease (PD) patients exhibit lower body weight when compared to age-matched healthy subjects. Low body mass index (BMI) is correlated with low bone mineral density, both of which are major risk factors for hip fractures. Possible determinants of weight loss in PD patients include hyposmia, impaired hand-mouth coordination, difficulty chewing, dysphagia, intestinal hypomotility, depression, decreased reward processing of dopaminergic mesolimbic regions, nausea, and anorexia as the side effects of medication, and increased energy requirements due to muscular rigidity and involuntary movements. It is unclear whether PD patients in general, or only a subgroup of those affected, definitely show lower BMI in the advanced stages of the disease. We therefore recommend that the body weight of PD patients be monitored monthly as the disease progresses, and that a patient's nutrition should be supplemented with sufficient amounts of vitamin D and calcium to reduce the risk of hip fractures and strengthen bone density. Because meal times may coincide with unpredictable off periods associated with akinesia and impaired hand-mouth coordination, PD patients also need flexible food schedules that accommodate the associated symptoms of this disease.

Entities:  

Mesh:

Year:  2006        PMID: 16958133     DOI: 10.1002/mds.21068

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  47 in total

1.  Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.

Authors:  Anne-Marie A Wills; Adriana Pérez; Jue Wang; Xiao Su; John Morgan; Suja S Rajan; Maureen A Leehey; Gregory M Pontone; Kelvin L Chou; Chizoba Umeh; Zoltan Mari; James Boyd
Journal:  JAMA Neurol       Date:  2016-03       Impact factor: 18.302

2.  An exploratory study of activity in veterans with Parkinson's disease.

Authors:  Marilyn Trail; Nancy J Petersen; Naomi Nelson; Eugene C Lai
Journal:  J Neurol       Date:  2012-08       Impact factor: 4.849

3.  Predictors of weight loss in early treated Parkinson's disease from the NET-PD LS-1 cohort.

Authors:  Anne-Marie Wills; Ruosha Li; Adriana Pérez; Xuehan Ren; James Boyd
Journal:  J Neurol       Date:  2017-07-15       Impact factor: 4.849

4.  Nutritional support by "conventional" percutaneous endoscopic gastrostomy feeding may not result in weight gain in Parkinson's disease.

Authors:  Yuu Yamazaki; Keitaro Kobatake; Mutsuhiro Hara; Makoto Katagiri; Masayasu Matsumoto
Journal:  J Neurol       Date:  2011-03-10       Impact factor: 4.849

Review 5.  Sleep-disordered breathing in neurodegenerative diseases.

Authors:  Carles Gaig; Alex Iranzo
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

6.  Influences of levodopa on adipose tissue and skeletal muscle metabolism in patients with idiopathic Parkinson's disease.

Authors:  Frauke Adams; Michael Boschmann; Elmar Lobsien; Andreas Kupsch; Axel Lipp; Gabriele Franke; Marie Charlotte Leisse; Juergen Janke; Simone Gottschalk; Joachim Spranger; Jens Jordan
Journal:  Eur J Clin Pharmacol       Date:  2008-07-30       Impact factor: 2.953

7.  Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism.

Authors:  Zane B Andrews; Derek Erion; Rudolph Beiler; Zhong-Wu Liu; Alfonso Abizaid; Jeffrey Zigman; John D Elsworth; Joseph M Savitt; Richard DiMarchi; Matthias Tschoep; Robert H Roth; Xiao-Bing Gao; Tamas L Horvath
Journal:  J Neurosci       Date:  2009-11-11       Impact factor: 6.167

Review 8.  Metabolic hormones, dopamine circuits, and feeding.

Authors:  Nandakumar S Narayanan; Douglas J Guarnieri; Ralph J DiLeone
Journal:  Front Neuroendocrinol       Date:  2009-10-28       Impact factor: 8.606

9.  Chocolate consumption is increased in Parkinson's disease. Results from a self-questionnaire study.

Authors:  Martin Wolz; Alice Kaminsky; Matthias Löhle; Rainer Koch; Alexander Storch; Heinz Reichmann
Journal:  J Neurol       Date:  2009-03-13       Impact factor: 4.849

10.  Immediate effects of thermal-tactile stimulation on timing of swallow in idiopathic Parkinson's disease.

Authors:  Julie Regan; Margaret Walshe; W Oliver Tobin
Journal:  Dysphagia       Date:  2009-08-26       Impact factor: 3.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.